Association of KLF5 gene rs11841589 polymorphism with the risk of endometrial cancer
F.R. NUHBALA, R.I. GABIDULLINA
Kazan State Medical University of the Ministry of Health of the Russian Federation, Kazan
Contact:
Nuhbala F.R. ― postgraduate student of the Department of Obstetrics and Gynecology named after V.S. Gruzdev
Address: 49 Butlerov Str., 420012, Kazan, Russian Federation, tel. +7-950-313-37-34, e-mail: nuhbala_fikret@mail.ru
Objective. To analyze the prevalence of KLF5 gene rs11841589 polymorphism variants and to reveal its association with the risk of endometrial cancer.
Material and methods. The study included 161 female residents of the Republic of Tatarstan. The main group consisted of 60 patients with endometrial cancer and the control group – of 101 women without endometrial pathology. The average age was 61.3 (8.8) y.o. in the main group and 65.5 (5.4) y.o. in the control group (р<0.05). Determination of KLF5 gene rs11841589 polymorphism was carried out with the method of real time polymerase chain reaction. The χ2 test was performed and the odds ratio indicator was evaluated.
Results. It was established that the presence of the G allele and the G/G genotype of the KLF5 gene rs18841589 polymorphism does not increase the risk of endometrial cancer in women living in the Republic of Tatarstan. G allele (79.7% against 72.5%; χ2= 2.21, p = 0.14; OR = 0.67, 95% CI 0.40–1.14) and G/G genotype (55.0% against 66.3%; χ2= 2.08, p = 0.35; OR = 0.62, 95% CI 0.32–1.19) occurs in the endometrial cancer group and in the control group without statistical significance. The prevalence of alleles and genotypes of the KLF5 gene was comparable with the European one.
Conclusion. The study revealed that the associations of KLF5 gene rs18841589 polymorphism with the risk of endometrial cancer in the 161 female residents of the Republic of Tatarstan were not identified.
Key words: endometrial cancer, polymorphism, gene.
REFERENCES
- Bray F. et al. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. A Cancer Journal for Clinicians, 2018, pp. 1-31, avaialble at: https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21492
- Kaprin A.D., Starinskiy V.V., Petrova G.V. Zlokachestvennye novoobrazovaniya v Rossii v 2017 godu (zabolevaemost’ i smertnost) [Malignant neoplasms in Russia in 2017 (morbidity and mortality)]. Moscow: MNIOI im. P.A. Gertsena – filial FGBU «NMITs radiologii» Minzdrava Rossii, 2018. 250 p.
- Ferlay J., Colombet M., Soerjomataram I., Dyba T., Randi G. et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer, 2018, no. 103, pp. 356-387 doi: 10.1016/j.ejca.2018.07.005.
- 1000 Genomes Project Phase 3, Ensembl 2019, available at: http://www.ensembl.org
- Cheng T.H., Thompson D.J., O’Mara T.A., Painter J.N., Glubb D.M. et al. Five endometrial cancer risk loci identified through genome-wide association analysis. NatGenet., 2016, no. 48 (6), pp. 667-674. doi: 10.1038/ng.3562.
- Davis H., Lewis A., Spencer-Dene B., Tateossian H., Stamp G. et al. FBXW7 mutations typically found in human cancers are distinct from null alleles and disrupt lung development. J Pathol., 2011, no. 224, pp. 180-189. doi: 10.1002/path.2874.
- Mutter G.L., Baak J.P., Fitzgerald J.T., Gray R., Neuberg D. et al. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. GynecolOncol., 2001, no. 83, pp. 177-185.
- Shi H., Zhang Z., Wang X., Liu S., Teng C.T. Isolation and characterization of a gene encoding human Kruppel-like factor 5 (IKLF): binding to the CAAT/GT box of the mouse lactoferrin gene promoter. Nucleic Acids Res., 1999, no. 27, pp. 4807-4815.
- Simmen R.C., Pabona J.M. Velarde M.C., Simmons C., Rahal O., Simmen F.A. The emerging role of Kruppel-like factors in endocrine-responsive cancers of female reproductive tissues. J Endocrinol., 2010, no. 204, pp. 223-231. doi: 10.1677/JOE-09-0329.
- Forbes S.A., Bhamra G., Bamford S., Dawson E., Kok C. et al. The Catalogue of Somatic Mutations in Cancer (COSMIC) CurrProtoc Hum Genet., 2008, chapter 10:Unit 10 11. doi: 10.1002/0471142905.hg1011s57.